Tenshi Pharmaceuticals’ promoter group has increased its stake in Onesource Speciality Pharma through open market purchases. The acquisition involved 200,000 equity shares, raising the promoter group’s total holding to 3,44,96,199 shares, representing 30.10% of the total share/voting capital. The transaction was completed on January 28, 2026.
Promoter Group Acquisition
The promoter group of Tenshi Pharmaceuticals has acquired additional equity shares of Onesource Speciality Pharma, further solidifying its position in the company. This move reflects the promoter group’s confidence in the future prospects and strategic direction of Onesource.
Details of the Transaction
On January 28, 2026, the promoter group acquired 200,000 equity shares of Onesource Speciality Pharma through open market purchases. This acquisition has increased their total holding to 3,44,96,199 shares.
Impact on Shareholding
Prior to this acquisition, the promoter group held 3,42,96,199 shares, representing 29.93% of the total share/voting capital. Following the acquisition of the additional 200,000 shares, their stake has increased to 30.10% of the total share/voting capital.
Equity and Voting Capital
The equity share capital/total voting capital of Onesource Speciality Pharma remains unchanged at 11,45,62,136 equity shares of Rs. 1 each, fully paid up, both before and after the acquisition.
Source: BSE
